This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, Z. Articles by Hollstein, M. C. Search for Related Content PubMed PubMed Citation Articles by Liu, Z. Articles by Hollstein, M. C.

p53 Mutations in Benzo(a)Pyrene-Exposed Human p53 Knock-in Murine Fibroblasts Correlate with p53 Mutations in Human Lung Tumors

Departments of ¹ Genetic Alterations in Carcinogenesis and ² Molecular Toxicology, German Cancer Research Center, Heidelberg, Germany

Requests for reprints: Monica C. Hollstein, Department of Genetic Alterations in Carcinogenesis, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany. Phone: 49-6221-42-33-02; Fax: 49-6221-42-33-42; E-mail: m.hollstein{at}dkfz-heidelberg.de.

Human p53 mutation spectra differ significantly from one cancer type to another. One possible reason is that carcinogenic risk factors differ, and these factors elicit distinct mutation patterns. There has been no mammalian assay, however, with which to generate mutation patterns in human p53 sequences experimentally, hampering interpretation of the human tumor spectra. We have designed a new mammalian cell assay using gene targeting technology that selects and scores human p53 gene sequence mutations in human-p53 knock-in (Hupki) murine embryonic fibroblasts (HUF) that have undergone immortalization. With the Hupki assay we examined here whether benzo(a)pyrene (BaP), a major tobacco smoke carcinogen could elicit p53 mutation patterns characterizing the human lung tumor p53 mutation spectrum. We found that, in contrast to unexposed HUFs or HUFs exposed to other carcinogenic agents, HUFs exposed to BaP acquire mutations that display major features of the human lung tumor p53 mutation spectrum: (a) predominance of G-to-T mutations, (b) unequivocal strand bias of the transversions, and (c) a mutation hotspot at codons 157 to 158. These data are consistent with the hypothesis that BaP has a direct role in causing smokers' lung tumor p53 mutations. The assay can be used to examine various hypotheses on the endogenous or exogenous factors responsible for the p53 mutations in human tumors arising in other tissues.

Key Words: tumor suppressor • mutation spectrum • Benzo(a)pyrene • gene targeting • carcinogen

This article has been cited by other articles:

				J. vom Brocke, A. Krais, C. Whibley, M. C. Hollstein, and H. H. Schmeiser The carcinogenic air pollutant 3-nitrobenzanthrone induces GC to TA transversion mutations in human p53 sequences Mutagenesis, January 1, 2009; 24(1): 17 - 23. [Abstract] [Full Text] [PDF]

				D. A. Delker, D. R. Geter, K. M. Kleinert, and B. B. Gollapudi Frequency and Spectrum of lacI Mutations in the Liver of Big Blue Mice Following the Administration of Genotoxic Carcinogens Singly and in Series International Journal of Toxicology, January 1, 2008; 27(1): 35 - 42. [Abstract] [Full Text] [PDF]

				S. L. Hockley, V. M. Arlt, G. Jahnke, A. Hartwig, I. Giddings, and D. H. Phillips Identification through microarray gene expression analysis of cellular responses to benzo(a)pyrene and its diol-epoxide that are dependent or independent of p53 Carcinogenesis, January 1, 2008; 29(1): 202 - 210. [Abstract] [Full Text] [PDF]

				U. Cardellino, Y. Ciribilli, V. Andreotti, P. Modesto, P. Menichini, G. Fronza, C. Pellegrino, and A. Inga Transcriptional properties of feline p53 and its tumour-associated mutants: a yeast-based approach Mutagenesis, November 1, 2007; 22(6): 417 - 423. [Abstract] [Full Text] [PDF]

				V. M. Arlt, E. Frei, and H. H. Schmeiser ECNIS-sponsored workshop on biomarkers of exposure and cancer risk: DNA damage and DNA adduct detection and 6th GUM-32P-postlabelling workshop, German Cancer Research Center, Heidelberg, Germany, 29-30 September 2006 Mutagenesis, January 1, 2007; 22(1): 83 - 88. [Abstract] [Full Text] [PDF]

				J. v. Brocke, H. H. Schmeiser, M. Reinbold, and M. Hollstein MEF immortalization to investigate the ins and outs of mutagenesis Carcinogenesis, November 1, 2006; 27(11): 2141 - 2147. [Abstract] [Full Text] [PDF]

				C. Dudgeon, C. Kek, O. N. Demidov, S.-i. Saito, K. Fernandes, A. Diot, J.-C. Bourdon, D. P. Lane, E. Appella, A. J. Fornace Jr., et al. Tumor Susceptibility and Apoptosis Defect in a Mouse Strain Expressing a Human p53 Transgene. Cancer Res., March 15, 2006; 66(6): 2928 - 2936. [Abstract] [Full Text] [PDF]

				V. M. Arlt 3-Nitrobenzanthrone, a potential human cancer hazard in diesel exhaust and urban air pollution: a review of the evidence Mutagenesis, November 1, 2005; 20(6): 399 - 410. [Abstract] [Full Text] [PDF]